Ceeable Selected for IBM Global Entrepreneur Program
Company will utilize IBM cloud platform and Watson artificial intelligence capabilities to detect vision disorders.
Somerville, MA, August 08, 2017 --(PR.com)-- Ceeable, Inc. has been selected to become part of the IBM Global Entrepreneur Program. As part of the program Ceeable will use the IBM cloud capabilities to enhance its technical capabilities and software based business model. The company will use the artificial intelligence tools of the IBM Watson program to analyze test data generated by its proprietary visual field testing system (CVFA). The combination of the two technologies will lead to better ways of detecting and diagnosing eye disease.
The funded yearlong IBM Global Entrepreneur Program is a gateway into a global ecosystem of top business leaders and investors, technical experts, and enterprise clients. Promising technology companies are selected into the program based on several factors, including unique technical solutions and market opportunity.
About Ceeable
Ceeable, Inc. is a leader in digital mobile health for ophthalmology. The Ceeable Visual Field Analyzer (CVFA) is a cloud-based digital platform used to detect and diagnose retinal disease. There are more than 300 million people worldwide that suffer from retinal and optic nerve disease. The Ceeable technology has the ability to reach more people worldwide than any currently available eye disorder diagnostic technology. Better patient management of eye disease will reduce healthcare systems costs and help prevent blindness.
The funded yearlong IBM Global Entrepreneur Program is a gateway into a global ecosystem of top business leaders and investors, technical experts, and enterprise clients. Promising technology companies are selected into the program based on several factors, including unique technical solutions and market opportunity.
About Ceeable
Ceeable, Inc. is a leader in digital mobile health for ophthalmology. The Ceeable Visual Field Analyzer (CVFA) is a cloud-based digital platform used to detect and diagnose retinal disease. There are more than 300 million people worldwide that suffer from retinal and optic nerve disease. The Ceeable technology has the ability to reach more people worldwide than any currently available eye disorder diagnostic technology. Better patient management of eye disease will reduce healthcare systems costs and help prevent blindness.
Contact
Ceeable
Chris Adams
617-957-9858
ceeable.com
Contact
Chris Adams
617-957-9858
ceeable.com
Categories